Mechanistically, erastin and APAP sensitize tumor cells to ferroptosis by regulating nucleus translocation of NRF2 and the following downregulation of HMOX1 and transferrin, which led to elevated levels of LIP and thus making NSCLC cells sensitized to ferroptosis [23, 24, 89]. The gene discussed is NFE2L2; the disease is neoplasm.